Medixall Group Inc Quick Ratio (CRCX) starting from the third quarter 2024 to third quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Medixall Group Inc   (CRCX)
    Sector • Transportation    Industry • Railroads
   Industry • Railroads
   Sector • Transportation

Medixall Group Inc 's Quick Ratio

CRCX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Current Liabilities decreased faster than Medixall Group Inc 's Cash & cash equivalent, this led to improvement in Medixall Group Inc 's Quick Ratio to 0.01, Quick Ratio remained below Medixall Group Inc average.

Within Railroads industry 7 other companies have achieved higher Quick Ratio than Medixall Group Inc in third quarter 2024. While Quick Ratio total ranking in the third quarter 2024 has deteriorated compared to the prior quarter from 4646 to 4870.

Explain Quick Ratio?
How much Cash & cash equivalents CRCX´s has?
What are CRCX´s Current Liabilities?




CRCX Quick Ratio (Sep 30 2024)
Q3
(Jun 30 2024)
Q2
(Mar 31 2024)
Q1
(Dec 31 2023)
Q4
(Sep 30 2023)
Q3
Y / Y Current Liabilities Change -33.51 % 44.09 % 44.67 % -27.23 % 54.5 %
Y / Y Cash & cash equivalent Change 230.15 % 75.64 % 2250.94 % 213.85 % -87.21 %
Quick Ratio MRQ 0.01 0 0.01 0 0
CRCX's Total Ranking # 4870 # 4646 # 4564 # 4749 # 5832
Seq. Current Liabilities Change -50.61 % 6.36 % 128.5 % -44.61 % 7.03 %
Seq. Cash & cash equivalent Change -2.16 % -39.38 % 401.94 % 10.9 % -47.95 %



Quick Ratio third quarter 2024 Company Ranking
Within: No.
Railroads Industry # 8
Transportation Sector # 109
Overall Market # 4870


Quick Ratio Statistics
High Average Low
1.41 0.3 0
(Sep 30 2020)   (Sep 30 2015)




Financial Statements
Medixall Group Inc 's Current Liabilities $ 4 Millions Visit CRCX's Balance sheet
Medixall Group Inc 's Cash & cash equivalent $ 0 Millions Visit CRCX's Balance sheet
Source of CRCX's Sales Visit CRCX's Sales by Geography


Cumulative Medixall Group Inc 's Quick Ratio

CRCX's Quick Ratio for the trailling 12 Months

CRCX Quick Ratio

(Sep 30 2024)
12 Months
(Jun 30 2024)
12 Months
(Mar 31 2024)
12 Months
(Dec 31 2023)
12 Months
(Sep 30 2023)
12 Months
Y / Y Current Liabilities TTM Growth 7.29 % 29.47 % 42.65 % 73.89 % 157.28 %
Y / Y Cash & cash equivalent TTM Growth 280.24 % 6.98 % -63.64 % -88.44 % -91.85 %
Quick Ratio TTM 0.01 0 0 0 0
Total Ranking TTM # 3658 # 3719 # 3661 # 4091 # 4676
Seq. Current Liabilities TTM Growth -8.04 % 10.97 % 11.62 % -5.8 % 10.96 %
Seq. Cash & cash equivalent TTM Growth 20.83 % 15.14 % 124.91 % 21.52 % -66.01 %


On the trailing twelve months basis CRCX Cash & cash equivalent more than doubled by 230.15 % in Q3 2024 year on year, while Current Liabilities dropped to $4 millions, this led to